Tower Research Capital LLC (Trc) Day One Biopharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,657 shares of DAWN stock, worth $87,707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,657
Previous 1,054
911.1%
Holding current value
$87,707
Previous $14,000
864.29%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding DAWN
# of Institutions
176Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$52.9 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$48.1 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$47.4 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$40.1 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$37.3 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $605M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...